WARREN, N.J., March 7, 2019 /PRNewswire/ — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, today announced that management will present at Oppenheimer’s 29th Annual Healthcare Conference to be held in New York, NY on March 19 – 20.
Aquestive will present on Tuesday, March 19 at 2:45 p.m. Eastern Time. A webcast of the presentation will be available on the “Events and Presentation” page of the Investors section of the Company’s website. For more information, please visit investors.aquestive.com.
About Aquestive Therapeutics
Aquestive Therapeutics is a specialty pharmaceutical company that applies innovative technology to solve therapeutic problems and improve medicines for patients. Aquestive is advancing a late-stage proprietary product pipeline to treat CNS conditions and provide alternatives to invasively-administered standard of care therapies. The company also collaborates with pharmaceutical partners to bring new molecules to market using proprietary, best-in-class technologies, like PharmFilm®, and has proven capabilities for drug development and commercialization.
View original content to download multimedia:http://www.prnewswire.com/news-releases/aquestive-therapeutics-to-present-at-oppenheimers-29th-annual-healthcare-conference-300808790.html
SOURCE Aquestive Therapeutics, Inc.